{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:31:37Z","timestamp":1793316697243,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Exc 257 NeuroCure"],"award-info":[{"award-number":["Exc 257 NeuroCure"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Psychiatric comorbidities are relevant in patients with Myasthenia gravis (MG). Also, MG patients experience a reduced health-related quality of life (HRQoL). We aimed to quantify the impact of depression as well as self-perceived MG severity on HRQoL and caregivers' burden. In this cross-sectional study, we used a survey encompassing demographic, disease-related information, and standardized questionnaires to assess symptoms of depression, anxiety, HRQoL (MG Quality of Life scale; MG-QoL15), and caregiver burden (Burden Scale for Family Caregivers; BSFC). Data from 1399 participating patients (96%) and 1042 caregivers (65%) were eligible for further analysis. Symptoms of depression and anxiety disorder were indicated by 31% and 36% of patients. Self-reported MG severity (MG severity) and MG-QoL15 scores were strongly associated (estimated marginal means for severe versus mild MG severity\u2009=\u200918 95% CI [16; 21]; <jats:italic>p<\/jats:italic>\u2009\u2264\u20090.001). Adjusting for symptoms of depression decreased the estimated strength of this association (estimated marginal means for severe versus mild MG severity\u2009=\u200915 [13; 17]; <jats:italic>p<\/jats:italic>\u2009\u2264\u20090.001). Caregiver burden was associated to MG disease severity (estimated marginal means for severe vs. mild MG severity\u2009=\u20090.16 [0.13; 0,19); <jats:italic>p<\/jats:italic>\u2009\u2264\u20090.001) and also negatively influenced by symptoms of depression (estimated marginal means\u2009=\u20090.12 [0.09; 0.15]). Symptoms of depression and anxiety disorder in MG are frequent. Beyond MG severity, symptoms of depression have negative effects on HRQoL as well as on caregivers\u2019 burden. Diagnosis and treatment of psychiatric comorbidities should be considered an important element in MG care. Screening tools for mental health conditions should be implemented at least in specialized MG centers.<\/jats:p>","DOI":"10.1038\/s41598-022-22078-3","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T11:02:36Z","timestamp":1668164556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Mental health in myasthenia gravis patients and its impact on caregiver burden"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3409-4220","authenticated-orcid":false,"given":"Derin","family":"Marbin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0147-8992","authenticated-orcid":false,"given":"Sophie K.","family":"Piper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9007-027X","authenticated-orcid":false,"given":"Sophie","family":"Lehnerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0533-1434","authenticated-orcid":false,"given":"Ulrike","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7233-5342","authenticated-orcid":false,"given":"Andreas","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"issue":"5\u20136","key":"22078_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3109\/08916931003602130","volume":"43","author":"JJGM Verschuuren","year":"2010","unstructured":"Verschuuren, J. J. G. M., Palace, J. & Gilhus, N. E. Clinical aspects of myasthenia explained. Autoimmunity 43(5\u20136), 344\u2013352 (2010).","journal-title":"Autoimmunity"},{"issue":"1","key":"22078_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2377-10-46","volume":"10","author":"AS Carr","year":"2010","unstructured":"Carr, A. S., Cardwell, C. R., McCarron, P. O. & McConville, J. A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol. 10(1), 46. https:\/\/doi.org\/10.1186\/1471-2377-10-46 (2010).","journal-title":"BMC Neurol."},{"issue":"2","key":"22078_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/1756285608093888","volume":"1","author":"R Gold","year":"2008","unstructured":"Gold, R., Hohlfeld, R. & Toyka, K. V. Progress in the treatment of myasthenia gravis. Ther. Adv. Neurol. Disord. 1(2), 36\u201351 (2008).","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"5","key":"22078_CR4","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1212\/WNL.48.5.1253","volume":"48","author":"CE Thomas","year":"1997","unstructured":"Thomas, C. E. et al. Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology 48(5), 1253\u20131260 (1997).","journal-title":"Neurology"},{"key":"22078_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12955-015-0298-1","volume":"13","author":"MI Boldingh","year":"2015","unstructured":"Boldingh, M. I. et al. An up-date on health-related quality of life in myasthenia gravis -results from population based cohorts. Health Qual. Life Outcomes 13, 115 (2015).","journal-title":"Health Qual. Life Outcomes"},{"issue":"6","key":"22078_CR6","first-page":"1375","volume":"33","author":"IZ Basta","year":"2012","unstructured":"Basta, I. Z. et al. Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia). Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol. 33(6), 1375\u20131381 (2012).","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"issue":"14","key":"22078_CR7","doi-asserted-by":"publisher","first-page":"e1382","DOI":"10.1212\/WNL.0000000000012604","volume":"97","author":"M Petersson","year":"2021","unstructured":"Petersson, M. et al. Patient-reported symptom severity in a nationwide myasthenia gravis cohort: Cross-sectional analysis of the Swedish GEMG study. Neurology 97(14), e1382\u2013e1391 (2021).","journal-title":"Neurology"},{"issue":"45","key":"22078_CR8","first-page":"3176","volume":"90","author":"L Qiu","year":"2010","unstructured":"Qiu, L. et al. Study of incidence and correlation factors of depression, anxiety and insomnia in patients with myasthenia gravis. Zhonghua Yi Xue Za Zhi 90(45), 3176\u20133179 (2010).","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"2","key":"22078_CR9","doi-asserted-by":"publisher","first-page":"e000313","DOI":"10.1136\/bmjopen-2011-000313","volume":"1","author":"Y Suzuki","year":"2011","unstructured":"Suzuki, Y. et al. Factors associated with depressive state in patients with myasthenia gravis: A multicentre cross-sectional study. BMJ Open 1(2), e000313 (2011).","journal-title":"BMJ Open"},{"issue":"1","key":"22078_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1477-7525-8-129","volume":"8","author":"S Twork","year":"2010","unstructured":"Twork, S., Wiesmeth, S., Klewer, J., P\u00f6hlau, D. & Kugler, J. Quality of life and life circumstances in German myasthenia gravis patients. Health Qual. Life Outcomes 8(1), 129. https:\/\/doi.org\/10.1186\/1477-7525-8-129 (2010).","journal-title":"Health Qual. Life Outcomes"},{"key":"22078_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-010-5549-9","author":"Y Winter","year":"2010","unstructured":"Winter, Y. et al. Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy. J. Neurol. https:\/\/doi.org\/10.1007\/s00415-010-5549-9 (2010).","journal-title":"J. Neurol."},{"issue":"7","key":"22078_CR12","first-page":"e9184","volume":"12","author":"C Law","year":"2020","unstructured":"Law, C., Flaherty, C. V. & Bandyopadhyay, S. A review of psychiatric comorbidity in Myasthenia gravis. Cureus 12(7), e9184 (2020).","journal-title":"Cureus"},{"issue":"3","key":"22078_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.yebeh.2005.02.008","volume":"6","author":"AM Kanner","year":"2005","unstructured":"Kanner, A. M. Should neurologists be trained to recognize and treat comorbid depression of neurologic disorders? Yes. Epilepsy Behav. 6(3), 303\u2013311 (2005).","journal-title":"Epilepsy Behav."},{"issue":"48","key":"22078_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1026\/\/0012-1924.48.2.112","volume":"1","author":"A Hinz","year":"2002","unstructured":"Hinz, A., Schwarz, R., Herrmann, C., Buss, U. & Snaith, R. Hospital anxiety and depression scale - Deutsche Version(HADS-D). Diagnostica 1(48), 112\u2013113 (2002).","journal-title":"Diagnostica"},{"issue":"1","key":"22078_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mus.21883","volume":"43","author":"TM Burns","year":"2011","unstructured":"Burns, T. M., Grouse, C. K., Wolfe, G. I., Conaway, M. R. & Sanders, D. B. The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis. Muscle Nerve 43(1), 14\u201318 (2011).","journal-title":"Muscle Nerve"},{"issue":"6","key":"22078_CR16","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1176\/ajp.156.6.908","volume":"156","author":"N Breslau","year":"1999","unstructured":"Breslau, N., Peterson, E. L., Kessler, R. C. & Schultz, L. R. Short screening scale for DSM-IV posttraumatic stress disorder. Am. J. Psychiatry 156(6), 908\u2013911 (1999).","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"22078_CR17","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00115-008-2467-5","volume":"79","author":"A Maercker","year":"2008","unstructured":"Maercker, A., Forstmeier, S., Wagner, B., Glaesmer, H. & Br\u00e4hler, E. Posttraumatische Belastungsst\u00f6rungen in Deutschland. Nervenarzt 79(5), 577. https:\/\/doi.org\/10.1007\/s00115-008-2467-5 (2008).","journal-title":"Nervenarzt"},{"key":"22078_CR18","volume-title":"Psychosoz Onkol","author":"FA Muthny","year":"1989","unstructured":"Muthny, F. A. Freiburger Fragebogen zur Krankheitsverarbeitung. In Psychosoz Onkol (ed. Verres, R.) (Springer Verlag, 1989)."},{"key":"22078_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2318-14-23","volume":"14","author":"E Graessel","year":"2014","unstructured":"Graessel, E., Berth, H., Lichte, T. & Grau, H. Subjective caregiver burden: validity of the 10-item short version of the Burden scale for family caregivers BSFC-s. BMC Geriatr. 14, 23 (2014).","journal-title":"BMC Geriatr."},{"key":"22078_CR20","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1993.00540060055018","author":"S Doering","year":"1993","unstructured":"Doering, S., Henze, T. & Schussler, G. Coping With Myasthenia Gravis and implications for psychotherapy. Arch Neurol. https:\/\/doi.org\/10.1001\/archneur.1993.00540060055018 (1993).","journal-title":"Arch Neurol."},{"issue":"10","key":"22078_CR21","doi-asserted-by":"publisher","first-page":"e00538","DOI":"10.1002\/brb3.538","volume":"6","author":"S Hoffmann","year":"2016","unstructured":"Hoffmann, S. et al. Fatigue in myasthenia gravis: Risk factors and impact on quality of life. Brain Behav. 6(10), e00538 (2016).","journal-title":"Brain Behav."},{"issue":"69","key":"22078_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1590\/S0004-282X2011000200006","volume":"1","author":"M Ybarra","year":"2011","unstructured":"Ybarra, M. et al. Psychiatric disorders in myasthenia gravis. Arq. Neuropsiquiatr. 1(69), 176\u2013179 (2011).","journal-title":"Arq. Neuropsiquiatr."},{"issue":"1","key":"22078_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/01.cnd.0000138445.13978.e4","volume":"6","author":"J Lundeen","year":"2004","unstructured":"Lundeen, J., Fisher, J. & Kothari, M. J. Frequency of anxiety in myasthenia gravis. J. Clin. Neuromuscul. Dis. 6(1), 9\u201312 (2004).","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"22078_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13548506.2020.1807577","volume":"2","author":"C Liu","year":"2020","unstructured":"Liu, C., Li, T., Wang, Q., Xu, A. & Wu, B. Post-traumatic stress disorder symptoms after respiratory insufficiency in patients with myasthenia gravis. Psychol. Health Med. 2, 1\u20137. https:\/\/doi.org\/10.1080\/13548506.2020.1807577 (2020).","journal-title":"Psychol. Health Med."},{"issue":"1","key":"22078_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00115-013-3961-y","volume":"85","author":"F Jacobi","year":"2014","unstructured":"Jacobi, F. et al. Psychische St\u00f6rungen in der Allgemeinbev\u00f6lkerung. Studie zur gesundheit erwachsener in Deutschland und ihr zusatzmodul psychische gesundheit (DEGS1-MH). Nervenarzt. 85(1), 77\u201387 (2014).","journal-title":"Nervenarzt."},{"issue":"9","key":"22078_CR26","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2340\/16501977-2384","volume":"50","author":"L Rafsten","year":"2018","unstructured":"Rafsten, L., Danielsson, A. & Sunnerhagen, K. S. Anxiety after stroke: A systematic review and meta-analysis. J. Rehabil. Med. 50(9), 769\u2013778 (2018).","journal-title":"J. Rehabil. Med."},{"key":"22078_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.eurpsy.2016.11.004","volume":"41","author":"M P\u00e9rez-Pi\u00f1ar","year":"2017","unstructured":"P\u00e9rez-Pi\u00f1ar, M. et al. Anxiety disorders and risk of stroke: A systematic review and meta-analysis. Eur. Psychiatry 41, 102\u2013108 (2017).","journal-title":"Eur. Psychiatry"},{"key":"22078_CR28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jns.2016.11.067","volume":"372","author":"RE Boeschoten","year":"2017","unstructured":"Boeschoten, R. E. et al. Prevalence of depression and anxiety in multiple sclerosis: A systematic review and meta-analysis. J. Neurol. Sci. 372, 331\u2013341 (2017).","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"22078_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/JNN.0000000000000270","volume":"49","author":"SC Rogers","year":"2017","unstructured":"Rogers, S. C. Poststroke depression screening: An executive summary. J. Neurosci. Nurs. J. Am. Assoc. Neurosci. Nurses 49(2), 66\u201368 (2017).","journal-title":"J. Neurosci. Nurs. J. Am. Assoc. Neurosci. Nurses"},{"key":"22078_CR30","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200721060-00004","author":"IB Kulaksizoglu","year":"2007","unstructured":"Kulaksizoglu, I. B. Mood and anxiety disorders in patients with myasthenia gravis: Aetiology, diagnosis and treatment. CNS Drugs https:\/\/doi.org\/10.2165\/00023210-200721060-00004 (2007).","journal-title":"CNS Drugs"},{"issue":"8","key":"22078_CR31","first-page":"712","volume":"30","author":"J Perez-Nellar","year":"2000","unstructured":"Perez-Nellar, J. & Rodriguez, A. False negatives in the diagnosis of myasthenia gravis. Rev. Neurol. 30(8), 712\u2013715 (2000).","journal-title":"Rev. Neurol."},{"key":"22078_CR32","first-page":"157","volume":"19","author":"W Rohr","year":"1992","unstructured":"Rohr, W. Myasthenia gravis in the diagnostic frontier area of psychiatry. Psychiat. Prax. 19, 157\u2013163 (1992).","journal-title":"Psychiat. Prax."},{"key":"22078_CR33","first-page":"41","volume":"50","author":"NFT Braz","year":"2018","unstructured":"Braz, N. F. T. et al. Muscle strength and psychiatric symptoms influence health-related quality of life in patients with myasthenia gravis. J. Clin. Neurosci. Off. J. Neurosurg. Soc. Australas 50, 41\u201344 (2018).","journal-title":"J. Clin. Neurosci. Off. J. Neurosurg. Soc. Australas"},{"key":"22078_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/mus.26104","volume":"58","author":"I Lee","year":"2018","unstructured":"Lee, I., Kaminski, H. J., Xin, H. & Cutter, G. Gender and quality of life in myasthenia gravis patients from the myasthenia gravis foundation of America registry. Muscle Nerve 58, 90\u201398 (2018).","journal-title":"Muscle Nerve"},{"issue":"1","key":"22078_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/ene.14057","volume":"27","author":"A Bogdan","year":"2020","unstructured":"Bogdan, A. et al. Chronic stress, depression and personality type in patients with myasthenia gravis. Eur. J. Neurol. 27(1), 204\u2013209 (2020).","journal-title":"Eur. J. Neurol."},{"key":"22078_CR36","first-page":"84","volume":"79","author":"X Fan","year":"2020","unstructured":"Fan, X., Xing, C., Yang, L., Wang, J. & Feng, L. Fatigue, self-efficacy and psychiatric symptoms influence the quality of life in patients with myasthenia gravis in Tianjin, China. J. Clin. Neurosci. Off. J. Neurosurg. Soc. Australas 79, 84\u201389 (2020).","journal-title":"J. Clin. Neurosci. Off. J. Neurosurg. Soc. Australas"},{"issue":"2","key":"22078_CR37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/00006842-199803000-00006","volume":"60","author":"K Kroenke","year":"1998","unstructured":"Kroenke, K. & Spitzer, R. L. Gender differences in the reporting of physical and somatoform symptoms. Psychosom. Med. 60(2), 150\u2013155 (1998).","journal-title":"Psychosom. Med."},{"issue":"1","key":"22078_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0272-6386(12)80589-0","volume":"15","author":"CR Sacks","year":"1990","unstructured":"Sacks, C. R., Peterson, R. A. & Kimmel, P. L. Perception of illness and depression in chronic renal disease. Am. J. Kidney Dis. 15(1), 31\u20139. https:\/\/doi.org\/10.1016\/S0272-6386(12)80589-0 (1990).","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"22078_CR39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0022-3999(98)00073-7","volume":"46","author":"H Murphy","year":"1999","unstructured":"Murphy, H., Dickens, C., Creed, F. & Bernstein, R. Depression, illness perception and coping in rheumatoid arthritis. J. Psychosom. Res. 46(2), 155\u2013164 (1999).","journal-title":"J. Psychosom. Res."},{"issue":"7","key":"22078_CR40","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1080\/08870446.2012.759223","volume":"28","author":"P Steca","year":"2013","unstructured":"Steca, P. et al. How does illness severity influence depression, health satisfaction and life satisfaction in patients with cardiovascular disease? The mediating role of illness perception and self-efficacy beliefs. Psychol. Health 28(7), 765\u201383. https:\/\/doi.org\/10.1080\/08870446.2012.759223 (2013).","journal-title":"Psychol. Health"},{"issue":"6","key":"22078_CR41","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","volume":"375","author":"GI Wolfe","year":"2016","unstructured":"Wolfe, G. I. et al. Randomized trial of thymectomy in myasthenia gravis. N. Engl. J. Med. 375(6), 511\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1602489 (2016).","journal-title":"N. Engl. J. Med."},{"issue":"04","key":"22078_CR42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1055\/a-0582-9020","volume":"45","author":"JC R\u00fcckert","year":"2018","unstructured":"R\u00fcckert, J. C., Swierzy, M., Kohler, S., Meisel, A. & Ismail, M. Thymektomie bei myasthenia gravis TT - thymectomy in Myasthenia gravis. Aktuelle Neurol. 45(04), 263\u2013270 (2018).","journal-title":"Aktuelle Neurol."},{"issue":"2","key":"22078_CR43","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1177\/0898264304274179","volume":"17","author":"PR Sherwood","year":"2005","unstructured":"Sherwood, P. R., Given, C. W., Given, B. A. & von Eye, A. Caregiver burden and depressive symptoms: Analysis of common outcomes in caregivers of elderly patients. J. Aging Health 17(2), 125\u2013147. https:\/\/doi.org\/10.1177\/0898264304274179 (2005).","journal-title":"J. Aging Health"},{"issue":"2","key":"22078_CR44","doi-asserted-by":"publisher","first-page":"162","DOI":"10.2307\/2676303","volume":"41","author":"RA Miech","year":"2000","unstructured":"Miech, R. A. & Shanahan, M. J. Socioeconomic status and depression over the life course. J. Health Soc. Behav. 41(2), 162\u201376 (2000).","journal-title":"J. Health Soc. Behav."},{"key":"22078_CR45","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.socscimed.2007.12.019","volume":"66","author":"I Bjelland","year":"2008","unstructured":"Bjelland, I. et al. Does higher education protect against anxiety and depression? The HUNT study. Soc. Sci. Med. (1982) 66, 1334\u20131345 (2008).","journal-title":"Soc. Sci. Med. (1982)"},{"issue":"10159","key":"22078_CR46","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"SL James","year":"2018","unstructured":"James, S. L. et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: A systematic analysis for the Global Burden of disease study 2017. Lancet 392(10159), 1789\u2013858. https:\/\/doi.org\/10.1016\/S0140-6736(18)32279-7 (2018).","journal-title":"Lancet"},{"key":"22078_CR47","doi-asserted-by":"crossref","unstructured":"Stoppe, G., Bramesfeld, A., Schwartz, F.-W. (2006) Volkskrankheit Depression? Bestandsaufnahme und Perspektiven. Dtsch. Arztebl. Int. 103(22), A\u20131557. Available from: https:\/\/www.aerzteblatt.de\/int\/article.asp?id=51635.","DOI":"10.1007\/3-540-32221-3"},{"issue":"6","key":"22078_CR48","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/mus.25198","volume":"54","author":"TM Burns","year":"2016","unstructured":"Burns, T. M. et al. International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r. Muscle Nerve 54(6), 1015\u20131022 (2016).","journal-title":"Muscle Nerve"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22078-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22078-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22078-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T11:07:57Z","timestamp":1668164877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22078-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["22078"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-22078-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]},"assertion":[{"value":"2 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.L. has received speaker\u00b4s honoraria and honoraria for attendance of advisory boards from Alexion. A.M received speaker\u00b4s honoraria from Alexion, Grifols, and Hormosan. He received honoraria from Alexion, UCB, MorphoSys, and Argenx for consulting services and financial research support from Octapharma and Alexion. He is the chairman of the German Myasthenia Gravis Society\u2019s medical advisory board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19275"}}